Johnson & Johnson
Pharmaceuticals and medical technology · United States
Johnson & Johnson discovers and sells prescription medicines for cancer, immune and brain diseases, and medical devices for surgery, heart, orthopaedics and eye care, mostly through wholesalers and hospitals.
What makes it different
Its top product is a cancer drug, not a Band-Aid.
15.0%Sales from DARZALEXFY2025
One multiple myeloma medicine family now outsells every other product the company makes.
How big it is
How big is Johnson & Johnson?
$94.2BTotal salesFY2025
138,200EmployeesFY2025
63Manufacturing facilitiesFY2025
How it makes money FY2025
Medicines lead, devices follow.
- Innovative Medicine64%$60.4B
- MedTech36%$33.8B
How the business works
Medicines plus devices, constantly renewed.
- 1Cancer and immunology drugs
- 2Surgeons and hospitals
- 3Replace expiring-patent products
Newly launched products bring about a quarter of sales, offsetting products that lose patent protection.
Who owns it
- The Vanguard Group10.1%
- BlackRock, Inc.7.7%
- State Street Corporation5.5%
CEO: Joaquin Duato
Who it competes with
Key moments
- 1886Johnson & Johnson is founded
- 1944Johnson & Johnson goes public
- 1961Acquires Janssen Pharmaceutica
- 1987Launches ACUVUE disposable contact lenses
- 1998Acquires DePuy
Sources
Every number on this page comes from Johnson & Johnson's own reports.
Full profile
The rest of the story is in the app.
What Johnson & Johnson tracks22 metrics
Phase 3 indications in development
Employees
Indications under regulatory review
Results, quarter by quarterwith a chart
Revenue
Profit
Margin
Where the money comes from4 regions
United States
Europe
Asia-Pacific, Africa
The full timeline17 moments
2012
2024
2025
Johnson & Johnson vs Pfizerside by side
Revenue
Profit
People
Point your phone at a logo.
See the company behind it.
The full story in 12 chapters · compare any two companies · 335 companies, and any other on request.
Download on the App Store
